US Edition
News from Maddyness - Le Magazine sur l’actualité des Startups Françaises
We’ve assigned a media bias rating of unknown to Maddyness - Le Magazine Sur L’actualité Des Startups Françaises. You can read more about our methodology here.
Information about Maddyness - Le Magazine Sur L’actualité Des Startups Françaises
Where is Maddyness - Le Magazine Sur L’actualité Des Startups Françaises located?Maddyness - Le Magazine Sur L’actualité Des Startups Françaises's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Maddyness - Le Magazine Sur L’actualité Des Startups Françaises News
France Economy · FranceFrance's National Assembly rejected the proposed Zucman wealth tax on Friday evening with 228 lawmakers voting against and 172 in favor, according to parliamentary records from the lower house session.See the Story
France Rejects Zucman Wealth Tax, Approves Holding Company Levy
38% Center coverage: 44 sources
TechnologyAcquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a new standard of care in combination in first line unfit acute myeloid leukemia, an aggressive blood cancer affecting older adults Ipsen to acquire all issued and outstanding shares of ImCheck Therapeutics, for which ImCheck Therapeutics' shareholde…See the Story
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline - Ipsen (OTC:IPSEY)
60% Left coverage: 10 sources
